Business Context and Reporting Period
The submitted filing identifies Ambac Financial Group, Inc., not Octave Specialty Group Inc. It is an unaudited Form 10-Q for the quarter and nine months ended September 30, 2019, filed November 7, 2019. Ambac’s principal insurance subsidiaries are financial guarantee insurers in run-off. Its strategy focuses on reducing insured exposures, managing liabilities and investments, pursuing recoveries, and evaluating adjacent businesses.
Key Financial Metrics
| Metric | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2019 |
|---|---|---|
| Total revenues | $216.2 million | $405.7 million |
| Pre-tax income (loss) | $69.1 million | $(72.3) million |
| Net income (loss) attributable to common stockholders | $66.1 million | $(105.5) million |
| Diluted earnings (loss) per share | $1.41 | $(2.30) |
| Net cash used in operating activities | Not separately presented | $(296.2) million |
| Net cash provided by investing activities | Not separately presented | $791.4 million |
| Net cash used in financing activities | Not separately presented | $(510.6) million |
- Cash, cash equivalents and restricted cash totaled $67.7 million at September 30, 2019, compared with $83.5 million at year-end 2018.
- Total assets were $13.45 billion, total liabilities were $11.82 billion, and total stockholders’ equity was $1.63 billion.
- Investments totaled $3.94 billion, including $2.73 billion of fixed-income securities, $664.4 million of short-term investments, and $462.4 million of other investments.
- Reported long-term debt was $2.95 billion, consisting primarily of surplus notes, the Ambac Note, Tier 2 notes, and newly issued Ambac UK debt.
- Net premiums earned were $10.5 million for the quarter and $46.1 million for the nine-month period.
- Net investment income was $44.5 million for the quarter and $185.8 million for the nine-month period.
- Loss and loss expenses were $37.1 million for the quarter; the nine-month result was an $83.9 million benefit, primarily from favorable prior-year development.
- Insurance intangible amortization was $17.4 million for the quarter and $279.9 million for the nine-month period.
- Ambac Assurance’s statutory policyholder surplus was $1.25 billion at September 30, 2019, compared with $1.15 billion at December 31, 2018.
Material Changes Versus the Prior Comparable Period
- Quarterly net income attributable to common stockholders improved from a $103.8 million loss in the third quarter of 2018 to income of $66.1 million in the third quarter of 2019. The improvement was driven principally by a $142.2 million SEC/Citigroup settlement receipt recognized in other income and the absence of the $81.7 million 2018 loss associated with the auction market preferred shares exchange.
- For the nine months, results reversed from $206.2 million of income attributable to common stockholders in 2018 to a $105.5 million loss in 2019. The main adverse factors were $279.9 million of insurance intangible amortization, derivative losses, lower premiums and investment income, higher interest expense, and higher taxes.
- Net investment income declined by $13.8 million for the quarter and $49.4 million for the nine months, reflecting reduced holdings of higher-yielding Ambac-insured securities after restructuring transactions.
- Net gains on derivative contracts changed to a $9.9 million loss for the quarter and a $61.5 million loss for the nine months, compared with gains of $17.6 million and $51.7 million, respectively, in the prior-year periods. The 2019 losses primarily reflected lower forward interest rates.
- Net insured par exposure declined to $39.0 billion from $46.9 billion at December 31, 2018. Adversely classified credits declined to $7.7 billion from $10.9 billion, and watch-list credits declined to $8.0 billion from $9.0 billion.
- Premium receivables decreased to $414.7 million from $495.4 million, while the net insurance intangible asset declined to $433.5 million from $718.9 million.
Guidance, Outlook, Commentary, Risks and Unusual Items
- Management did not provide conventional earnings guidance. The filing emphasizes continued run-off, de-risking, commutations, reinsurance, loss recovery, liability management, and disciplined evaluation of new strategic opportunities.
- The February 2019 COFINA Plan of Adjustment and subsequent transactions reduced COFINA net par exposure to approximately $101.6 million at September 30, 2019. The transaction generated a reported gain, including a $14.9 million gain on consolidation of the COFINA Class 2 Trust.
- The June 2019 Ballantyne restructuring eliminated Ambac UK’s remaining Ballantyne exposure and reduced insured exposure by approximately $900 million, but produced an aggregate $83 million loss and materially accelerated insurance intangible amortization.
- Ambac received $142.2 million from an SEC settlement involving Citigroup and intended to use the proceeds to partially redeem the Ambac Note in December 2019.
- Puerto Rico remains the principal credit and litigation risk. Net Puerto Rico exposure was approximately $1.12 billion at September 30, 2019. Management recorded $196.6 million of domestic public finance losses for the nine-month period, primarily related to Puerto Rico uncertainty.
- Management estimated that adverse public-finance developments could increase loss reserves by approximately $1.1 billion, reducing Ambac Financial Group stockholders’ equity from $1.63 billion to approximately $528.7 million. Losses could exceed that estimate.
- Recorded RMBS representation-and-warranty recoveries were approximately $1.73 billion net of reinsurance. The filing states that recoveries are subject to significant litigation, collectability, timing, regulatory, and estimation risks.
- Ambac UK remained deficient under Solvency II: eligible capital resources were approximately £144 million versus regulatory capital requirements of £327 million, a deficiency of approximately £183 million. Discussions with regulators were ongoing.
- All ratings-based collateral triggers for certain derivatives had been triggered. Ambac had posted approximately $135 million of collateral and margin at September 30, 2019.
- Material risks include Puerto Rico restructuring outcomes, adverse loss-reserve development, failure to realize recoveries, regulatory restrictions imposed by Wisconsin’s insurance regulator, substantial indebtedness, liquidity constraints, litigation, interest-rate and foreign-currency volatility, Brexit, LIBOR transition, and potential rehabilitation proceedings for Ambac Assurance.
Important Facts for Investors to Verify
- Confirm the issuer identity: the supplied filing is for Ambac Financial Group, Inc., ticker AMBC, rather than Octave Specialty Group Inc.
- Assess the quality and realizability of the $1.73 billion of recorded RMBS representation-and-warranty recoveries.
- Review Puerto Rico plans of adjustment, litigation, creditor recoveries, and the potential $1.1 billion public-finance reserve stress.
- Evaluate Ambac UK’s regulatory capital deficiency and the feasibility of remediation with UK and European regulators.
- Reconcile reported cash and investments with collateral requirements, debt-service needs, claim payments, and restrictions on transfers from Ambac Assurance.
- Separate recurring run-off economics from unusual items, particularly the $142.2 million SEC settlement, the COFINA restructuring gain, the Ballantyne loss, and accelerated insurance intangible amortization.
- Review the filing’s non-GAAP Adjusted Earnings and Adjusted Book Value measures alongside, not instead of, GAAP results.